{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:19:23Z","timestamp":1768742363432,"version":"3.49.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the fact that many approaches have been developed over years to find efficient and well-tolerated therapeutic regimens for microsporidiosis, the effectiveness of current drugs remains doubtful, and effective drugs against specific targets are still scarce. The present study is the first that was designed to evaluate the potency of auranofin, an anti-rheumatoid FDA approved drug, against intestinal Encephalitozoon intestinalis. Evaluation of the drug was achieved through counting of fecal and intestinal spores, studying the intestinal histopathological changes, measuring of intestinal hydrogen peroxide level, and post therapy follow-up of mice for 2 weeks for detection of relapse. Results showed that auranofin has promising anti-microsporidia potential. It showed a promising efficacy in mice experimentally infected with E. intestinalis. It has revealed an obvious reduction in fecal spore shedding and intestinal tissue spore load, amelioration of intestinal tissue pathological changes, and improvement of the local inflammatory infiltration without significant changes in hydrogen peroxide level. Interestingly, auranofin prevented the relapse of infection. Thus, considering the results of the present work, auranofin could be considered a therapeutic alternative for the gold standard drug \u2018albendazole\u2019 against the intestinal E. intestinalis infection especially in relapsing cases.<\/jats:p>","DOI":"10.1093\/mmy\/myz126","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T12:12:25Z","timestamp":1574856745000},"source":"Crossref","is-referenced-by-count":4,"title":["Encephalitozoon intestinalis: A new target for auranofin in a mice model"],"prefix":"10.1093","author":[{"given":"I F","family":"Abou-El-Naga","sequence":"first","affiliation":[{"name":"Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M R","family":"Gaafar","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M M","family":"Gomaa","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S I","family":"Khedr","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S N El","family":"Achy","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Alexandria University, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"key":"2019122305080978600_bib1","first-page":"513","article-title":"Microsporidia: general characteristics, infections and laboratory diagnosis","volume":"39","author":"Sancak","year":"2005","journal-title":"Mikrobiyol Bul"},{"key":"2019122305080978600_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.FUNK-0018-2016","article-title":"Microsporidia: obligate intracellular pathogens within the fungal kingdom","volume":"5","author":"Han","year":"2017","journal-title":"Microbiol Spectr"},{"key":"2019122305080978600_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0001-706X(00)00178-9","article-title":"Microsporidia: emerging pathogenic protists","volume":"78","author":"Weiss","year":"2001","journal-title":"Acta Trop"},{"key":"2019122305080978600_bib4","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cub.2008.09.030","article-title":"Microsporidia evolved from ancestral sexual fungi","volume":"18","author":"Lee","year":"2008","journal-title":"Curr Biol"},{"key":"2019122305080978600_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.parint.2012.09.005","article-title":"Intestinal microsporidiosis in India: a two year study","volume":"62","author":"Saigal","year":"2013","journal-title":"Parasitol Int"},{"key":"2019122305080978600_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/QCO.0b013e32834aa152","article-title":"Microsporidiosis: not just in AIDS patients","volume":"24","author":"Didier","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"2019122305080978600_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.29252\/cmm.3.1.30","article-title":"Intestinal microsporidiosis in Iran: infection in immune-compromised and immunocompetent patients","volume":"3","author":"Nooshadokht","year":"2017","journal-title":"Curr Med Mycol"},{"key":"2019122305080978600_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.actatropica.2005.01.010","article-title":"Microsporidiosis: an emerging and opportunistic infection in humans and animals","volume":"94","author":"Didier","year":"2005","journal-title":"Acta Trop"},{"key":"2019122305080978600_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/14787210.3.3.419","article-title":"Therapeutic strategies for human microsporidia infections","volume":"3","author":"Didier","year":"2005","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"2019122305080978600_bib10","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1128\/AAC.00020-06","article-title":"Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo","volume":"50","author":"Didier","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2019122305080978600_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0163-4453(95)80034-4","article-title":"Intestinal microsporidiosis with Septata intestinalis in a patient with AIDS\u2014response to albendazole","volume":"31","author":"Franzen","year":"1995","journal-title":"J Infect."},{"key":"2019122305080978600_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1054\/drup.2000.0174","article-title":"Drug treatment of microsporidiosis","volume":"3","author":"Costa","year":"2000","journal-title":"Drug Resist Updat"},{"key":"2019122305080978600_bib13","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1128\/AAC.01113-08","article-title":"Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in a SCID mouse model","volume":"53","author":"Feng","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2019122305080978600_bib14","doi-asserted-by":"crossref","first-page":"e1002979","DOI":"10.1371\/journal.ppat.1002979","article-title":"The genome of the obligate intracellular parasite Trachipleistophora hominis: new insights into microsporidian genome dynamics and reductive evolution","volume":"8","author":"Heinz","year":"2012","journal-title":"PLoS Pathog"},{"key":"2019122305080978600_bib15","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4172\/2161-0673.1000152","article-title":"The association between physical exercise and Reactive Oxygen Species (ROS) production","volume":"5","author":"Nunes-Silva","year":"2015","journal-title":"J Sports Med Doping Stud"},{"key":"2019122305080978600_bib16","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/1535-7163.MCT-12-0968","article-title":"Drug repurposing for gastrointestinal stromal tumor","volume":"12","author":"Pessetto","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"2019122305080978600_bib17","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.1128\/AAC.03834-14","article-title":"Discovery of novel antigiardiasis drug candidates","volume":"58:","author":"Kulakova","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2019122305080978600_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.59.090506.155819","article-title":"The FDA critical path initiative and its influence on new drug development","volume":"59","author":"Woodcock","year":"2008","journal-title":"Annu Rev Med"},{"key":"2019122305080978600_bib19","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/rheumatology\/36.8.870","article-title":"Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis","volume":"36","author":"Glenn\u00e5s","year":"1997","journal-title":"Br J Rheumatol"},{"key":"2019122305080978600_bib20","doi-asserted-by":"crossref","first-page":"pii: e01947\u201316","DOI":"10.1128\/AAC.01947-16","article-title":"Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent","volume":"61","author":"Capparelli","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2019122305080978600_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10787-007-0021-x","article-title":"Clinical pharmacology of gold","volume":"16","author":"Kean","year":"2008","journal-title":"Inflammopharmacology"},{"key":"2019122305080978600_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","article-title":"Auranofin: repurposing an old drug for a golden new age","volume":"15","author":"Roder","year":"2015","journal-title":"Drugs R D"},{"key":"2019122305080978600_bib23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3892\/ijo.2014.2579","article-title":"Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53","volume":"45","author":"Park","year":"2014","journal-title":"Int J Oncol"},{"key":"2019122305080978600_bib24","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/AAC.01675-12","article-title":"A Reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia","volume":"57","author":"Tejman-Yarden","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019122305080978600_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijantimicag.2015.12.016","article-title":"Repurposing auranofin for the treatment of cutaneous staphylococcal infections","volume":"47","author":"Thangamani","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"2019122305080978600_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fcimb.2017.00004","article-title":"Repurposing approach identifies auranofin with broad spectrum antifungal activity that targets Mia40-Erv1 Pathway","volume":"7","author":"Thangamani","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2019122305080978600_bib27","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1038\/s41598-018-26674-0","article-title":"Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci","volume":"8","author":"Abdel Khalek","year":"2018","journal-title":"Sci Rep"},{"key":"2019122305080978600_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3460001","article-title":"Thioredoxin reductase","volume":"346","author":"Mustacich","year":"2000","journal-title":"Biochem J"},{"key":"2019122305080978600_bib29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A high throughput drug screen for Entamoeba histolytica identifies a new lead and target","volume":"18","author":"Debnath","year":"2012","journal-title":"Nat Med"},{"key":"2019122305080978600_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/9781555816018.ch27","article-title":"Macroscopic and microscopic Eexamination of faecal specimens","volume-title":"Diagnostic Medical Parasitology","author":"Garcia","year":"2007","edition":"4th edn"},{"key":"2019122305080978600_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1099\/jmm.0.026781-0","article-title":"Detection and species identification of microsporidial infection using SYBR Green real time PCR","volume":"60","author":"Polley","year":"2011","journal-title":"J Med Microbiol"},{"key":"2019122305080978600_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0020-7519(93)90077-C","article-title":"Identification of the microsporidian parasite, Enterocytozoon bieneusi in faecal samples and intestinal biopsies from an AIDS patient","volume":"23","author":"Lumb","year":"1993","journal-title":"Int J Parasitol"},{"key":"2019122305080978600_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.exppara.2011.01.017","article-title":"Evaluation of the co-agglutination test in diagnosis of experimental microsporidiosis","volume":"128","author":"Gaafar","year":"2011","journal-title":"Exp Parasitol"},{"key":"2019122305080978600_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/gmic.22596","article-title":"Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseases","volume":"4","author":"Debnath","year":"2013","journal-title":"Gut Microbes"},{"key":"2019122305080978600_bib35","doi-asserted-by":"crossref","first-page":"e60941","DOI":"10.1371\/journal.pone.0060941","article-title":"Latent microsporidiosis caused by Encephalitozoon cuniculi in immunocompetent hosts: a murine model demonstrating the ineffectiveness of the immune system and treatment with albendazole","volume":"8","author":"Kotkova","year":"2013","journal-title":"PLoS One"},{"key":"2019122305080978600_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/expr.1998.4267","article-title":"Encephalitozoon intestinalis: humoral responses in interferon-gamma receptor knockout mice infected with a microsporidium pathogenic in AIDS patients","volume":"89","author":"El-Fakhry","year":"1998","journal-title":"Exp Parasitol"},{"key":"2019122305080978600_bib37","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3382\/ps\/pex349","article-title":"Comparison of two methods for determination of intestinal villus to crypt ratios and documentation of early age-associated ratio changes in broiler chickens","volume":"97","author":"Wilson","year":"2018","journal-title":"Poultry Sci"},{"key":"2019122305080978600_bib38","volume-title":"Encyclopedia Of Statistical Sciences","author":"Kotz","year":"2005","edition":"2nd edn."},{"key":"2019122305080978600_bib39","first-page":"2","volume-title":"A Simple Guide to IBM SPSS Statistics for version 20.0","author":"Kirkpatrick","edition":"12th edn"},{"key":"2019122305080978600_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/B978-0-12-407706-5.00004-6","article-title":"Microsporidia and \u2018the art of living together\u2019","volume":"82","author":"V\u00e1vra","year":"2013","journal-title":"Adv Parasitol"},{"key":"2019122305080978600_bib41","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/jcp.46.8.694","article-title":"Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique","volume":"46","author":"van Gool","year":"1993","journal-title":"J Clin Pathol"},{"key":"2019122305080978600_bib42","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/515268","article-title":"Albendazole for treatment and prophylaxis of microsporidiosis Due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial","volume":"177","author":"Molina","year":"1998","journal-title":"J Infect Dis"},{"key":"2019122305080978600_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/mmy\/myy005","article-title":"A new scope for orlistat: effect of approved anti-obesity drug against experimental microsporidiosis","volume":"57","author":"Abou-El-Naga","year":"2019","journal-title":"Med Mycol"},{"key":"2019122305080978600_bib44","first-page":"19","article-title":"Pharmacology of auranofin: overview and update","volume":"63","author":"Gottlieb","year":"1986","journal-title":"Scand J Rheumatol Suppl"},{"key":"2019122305080978600_bib45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/EC.00283-10","article-title":"Immunolocalization of an alternative respiratory chain in Antonospora (Paranosema) locustae spores: mitosomes retain their role in microsporidial energy metabolism","volume":"10","author":"Dolgikh","year":"2011","journal-title":"Eukaryot Cell"},{"key":"2019122305080978600_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2005.02.016","article-title":"A real-containing ribonucleoprotein complex is required for mitotic spindle assembly","volume":"121","author":"Blower","year":"2005","journal-title":"Cell"},{"key":"2019122305080978600_bib47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/rheumatology\/36.5.560","article-title":"Auranofin","volume":"36","author":"Kean","year":"1997","journal-title":"Br J Rheumatol"},{"key":"2019122305080978600_bib48","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/JCM.33.11.2948-2952.1995","article-title":"Disseminated Encephalitozoon (Septata) intestinalis Infection in a patient with AIDS: novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole","volume":"33","author":"Sobottka","year":"1995","journal-title":"J Clin Microbiol"},{"key":"2019122305080978600_bib49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.12.2.243","article-title":"Molecular techniques for detection, species differentiation and phylogenetic analysis of microsporidia","volume":"12","author":"Franzen","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"2019122305080978600_bib50","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.172.7.4402","article-title":"Induction of a rapid and strong antigen specific intraepithelial lymphocyte response during oral Encephalitozoon cuniculi infection","volume":"172","author":"Moretto","year":"2004","journal-title":"J Immunol"},{"key":"2019122305080978600_bib51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/QAD.0b013e3280142ee8","article-title":"HIV enteropathy: crypt stem and transit cell hyper proliferation induces villous atrophy in HIV\/ microsporidia-infected jejunal mucosa","volume":"21","author":"Batman","year":"2007","journal-title":"AIDS"},{"key":"2019122305080978600_bib52","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1017\/S0031182099004904","article-title":"Emerging pathogens: Isospora, Cyclospora and microsporidia","volume":"117","author":"Curry","year":"1998","journal-title":"Parasitology"},{"key":"2019122305080978600_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2014.08.615","article-title":"Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst","volume":"276","author":"Madeira","year":"2014","journal-title":"J Neuroimmunol"},{"key":"2019122305080978600_bib54","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/IAI.40.3.936-942.1983","article-title":"Murine encephalitozoonosis model for studying the host-parasite relationship of a chronic infection","volume":"40","author":"Schmidt","year":"1983","journal-title":"Infect Immun"},{"key":"2019122305080978600_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00281-015-0482-8","article-title":"Effector CD8 T cell immunity in microsporidial infection: a lone defense mechanism","volume":"37","author":"Moretto","year":"2015","journal-title":"Semin Immunopathol"},{"key":"2019122305080978600_bib56","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1172\/JCI70522","article-title":"Intrinsic TGF-beta signaling promotes age-dependent CD8+ T cell polyfunctionality attrition","volume":"124","author":"Bhadra","year":"2014","journal-title":"J Clin Invest"},{"key":"2019122305080978600_bib57","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.micinf.2010.09.010","article-title":"Reactive nitrogen and oxygen species, and iron sequestration contribute to macrophage-mediated control of Encephalitozoon cuniculi (Phylum microsporidia) infection in vitro and in vivo","volume":"12","author":"Didier","year":"2010","journal-title":"Microbes Infect"},{"key":"2019122305080978600_bib58","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.febslet.2008.02.028","article-title":"New uses for old drugs. auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: mechanistic and pharmacological implications","volume":"582","author":"Sannellaa","year":"2008","journal-title":"FEBS Letters"},{"key":"2019122305080978600_bib59","doi-asserted-by":"crossref","first-page":"e0003534","DOI":"10.1371\/journal.pntd.0003534","article-title":"Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis","volume":"9","author":"Bulman","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2019122305080978600_bib60","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00726-011-0997-9","article-title":"A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition","volume":"42","author":"Ilari","year":"2012","journal-title":"Amino Acids"},{"key":"2019122305080978600_bib61","doi-asserted-by":"crossref","first-page":"28977","DOI":"10.1074\/jbc.M109.020701","article-title":"inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin, structural and kinetic aspects","volume":"284","author":"Angelucci","year":"2009","journal-title":"J Biol Chem"},{"key":"2019122305080978600_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2007.12.026","article-title":"Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells","volume":"582","author":"Rigobello","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2019122305080978600_bib63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biocel.2015.05.016","article-title":"Evidence that the antiproliferative effects of auranofin in Saccharomyces cerevisiaearise from inhibition of mitochondrial respiration","volume":"65","author":"Gamberi","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"2019122305080978600_bib64","doi-asserted-by":"crossref","first-page":"e1000761","DOI":"10.1371\/journal.ppat.1000761","article-title":"A broad distribution of the alternative oxidase in microsporidian parasites","volume":"6","author":"Williams","year":"2010","journal-title":"PLoS Pathog"},{"key":"2019122305080978600_bib65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nature00949","article-title":"A mitochondrial remnant in the microsporidian Trachipleistophora hominis","volume":"418","author":"Williams","year":"2002","journal-title":"Nature"},{"key":"2019122305080978600_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/viru.2.1.14606","article-title":"Shrink it or lose it: balancing loss of function with shrinking genomes in the microsporidia","volume":"2","author":"Keeling","year":"2011","journal-title":"Virulence"},{"key":"2019122305080978600_bib67","doi-asserted-by":"crossref","first-page":"e5658","DOI":"10.7717\/peerj.5658","article-title":"A secretory hexokinase plays an active role in the proliferation of Nosema bombycis","volume":"6","author":"Huang","year":"2018","journal-title":"Peer J"},{"key":"2019122305080978600_bib68","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1038\/s41598-018-26845-z","article-title":"First characterization of a microsporidial triosephosphate isomerase and the biochemical mechanisms of its inactivation to propose a new druggable target","volume":"8","author":"Garc\u00eda-Torres","year":"2018","journal-title":"Sci Rep"},{"key":"2019122305080978600_bib69","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00436-019-06279-w","article-title":"Heterologous overexpression of active hexokinases from microsporidia Nosema bombycis and Nosema ceranae confirms their ability to phosphorylate host glucose","volume":"118","author":"Dolgikh","year":"2019","journal-title":"Parasitol Res"},{"key":"2019122305080978600_bib70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41419-017-0159-4","article-title":"Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis","volume":"9","author":"Hou","year":"2018","journal-title":"Cell Death Dis"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myz126\/31591499\/myz126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myz126\/31591499\/myz126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:59:52Z","timestamp":1665104392000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article\/doi\/10.1093\/mmy\/myz126\/5685401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,23]]},"references-count":70,"URL":"https:\/\/doi.org\/10.1093\/mmy\/myz126","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,23]]},"article-number":"myz126"}}